February 1, 2017

Falanx Group Ltd Q&A with CEO Stuart Bladen & New Executive Director Jay Abbott (LON:FLX)

Falanx Group Ltd (LON:FLX) Chief Executive Officer Stuart Bladen and Executive Director Jay Abbott caught up with DirectorsTalk for an exclusive interview to discuss their three recent announcements; Operational Update,..

Epwin Group PLC FY16 in line with expectations, delivering c.19% earnings growth – Zeus Capital

Epwin Group PLC (LON:EPWN) year-end trading update states that results are in line with expectations which we take to be in line with consensus PBT forecasts of £24.4m, marginally above..

Savannah Resources Plc Ravene Drilling Programme Completed at Mutamba Project

Savannah Resources plc (LON:SAV), announced today that it has completed drilling at the Ravene deposit in Mozambique (Figures 1-3 – See PDF), which forms part of the Mutamba (mineral sands)..

Allergy Therapeutics plc Good Polyvac® Peanut preclinical results – Zeus Capital

Allergy Therapeutics Plc (LON:AGY) is a UK-based, specialty pharmaceutical company focused on the development, manufacture and sale of vaccines and other products for the treatment and prevention of allergies. This..

Quantum Pharma PLC Pre-close trading update – on plan

Quantum Pharma plc (LON:QP), the service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors, has released a pre-close trading update this morning. Zeus Capital said: The..

Search

Funds

February 1, 2017

Search

Funds

February 1, 2017

FTSE 100

Funds